We are trusted partners to our founders and co-investors. We use our deep scientific and industry networks to create exceptional value and shared success.
CHARLOTTESVILLE, Va. —Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation from the UVA Licensing &... Oxford, UK, 7th January 2020 – Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $7 million (UK £5 million) Series A round. The financing was co-...
Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies
Theolytics raises $7 million Series A co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies